111536
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
血清降钙素原与强直性脊柱炎伴髋关节受累患者疾病活动度评分的相关性
Received 10 February 2025
Accepted for publication 16 May 2025
Published 17 December 2025 Volume 2025:18 Pages 7605—7614
DOI https://doi.org/10.2147/IJGM.S516658
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Daniela Opriș-Belinski
XiaoXian Liang, BaoGui Deng
Department of Orthopedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People’s Republic of China
Correspondence: BaoGui Deng, Department of Orthopedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16, Airport Road, Baiyun District, Guangzhou, Guangdong, 510405, People’s Republic of China, Email dengbaogg123_d@hotmail.com
Background: To study the correlation analysis between serum procalcitonin (PCT) and Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients with hip involvement.
Methods: This prospective study collected 100 r-axSpA patients and 52 healthy controls. The BASRI-hip score was used to categorize r-axSpA patients into groups with no hip involvement (BASRI-hip=0, 1), mild involvement (BASRI-hip=2), and moderate-to-severe involvement (BASRI-hip=3, 4). Clinical characteristics of the groups were compared. The correlation between PCT, ASDAS, and BASRI-hip was assessed using the Spearman correlation analysis. ROC (Receiver Operating Characteristic) curves were produced to determine the area under the curve (AUC) of PCT and ASDAS in predicting the occurrence of hip involvement and the degree of hip involvement. Factors influencing hip involvement in r-axSpA were analyzed by multifactorial logistic regression.
Results: PCT levels were higher in r-axSpA patients than in healthy controls (p < 0.001). PCT and ASDAS were higher in the group with moderate-to-severe r-axSpA hip involvement than in the group without involvement and the group with mild involvement, while mild involvement was higher than that in the group without involvement (p < 0.05). Spearman correlation showed a positive correlation between PCT, ASDAS, and the degree of hip involvement. The area under the ROC curve (AUC) of PCT, ASDAS were 0.723 and 0.754 in predicting hip involvement, respectively; and the AUC of the severity of hip involvement were 0.733 and 0.718, respectively. PCT (OR = 1.11, 95% CI 1.04– 1.18, p < 0.01) and ASDAS (OR = 6.19, 95% CI 1.52– 235.12, p = 0.011) were the risk factors for hip involvement.
Conclusion: PCT and ASDAS show positive correlation with hip involvement in r-axSpA, and have a certain predictive value to react to hip involvement in r-axSpA.
Keywords: serum procalcitonin, disease activity score, ankylosing spondylitis, hip involvement, correlation analysis
Department of Orthopedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People’s Republic of China
Correspondence: BaoGui Deng, Department of Orthopedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16, Airport Road, Baiyun District, Guangzhou, Guangdong, 510405, People’s Republic of China, Email dengbaogg123_d@hotmail.com
Background: To study the correlation analysis between serum procalcitonin (PCT) and Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients with hip involvement.
Methods: This prospective study collected 100 r-axSpA patients and 52 healthy controls. The BASRI-hip score was used to categorize r-axSpA patients into groups with no hip involvement (BASRI-hip=0, 1), mild involvement (BASRI-hip=2), and moderate-to-severe involvement (BASRI-hip=3, 4). Clinical characteristics of the groups were compared. The correlation between PCT, ASDAS, and BASRI-hip was assessed using the Spearman correlation analysis. ROC (Receiver Operating Characteristic) curves were produced to determine the area under the curve (AUC) of PCT and ASDAS in predicting the occurrence of hip involvement and the degree of hip involvement. Factors influencing hip involvement in r-axSpA were analyzed by multifactorial logistic regression.
Results: PCT levels were higher in r-axSpA patients than in healthy controls (p < 0.001). PCT and ASDAS were higher in the group with moderate-to-severe r-axSpA hip involvement than in the group without involvement and the group with mild involvement, while mild involvement was higher than that in the group without involvement (p < 0.05). Spearman correlation showed a positive correlation between PCT, ASDAS, and the degree of hip involvement. The area under the ROC curve (AUC) of PCT, ASDAS were 0.723 and 0.754 in predicting hip involvement, respectively; and the AUC of the severity of hip involvement were 0.733 and 0.718, respectively. PCT (OR = 1.11, 95% CI 1.04– 1.18, p < 0.01) and ASDAS (OR = 6.19, 95% CI 1.52– 235.12, p = 0.011) were the risk factors for hip involvement.
Conclusion: PCT and ASDAS show positive correlation with hip involvement in r-axSpA, and have a certain predictive value to react to hip involvement in r-axSpA.
Keywords: serum procalcitonin, disease activity score, ankylosing spondylitis, hip involvement, correlation analysis